Cover Image

Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway

Abstract Background Cerebral ischemia is the second-leading cause of death and the main cause of permanent adult disabilities worldwide. Qingkailing (QKL) injection, a patented Chinese medicine approved by the China Food and Drug Administration, has been widely used in clinical practice to treat cer...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chongyang Ma (Author), Xueqian Wang (Author), Tian Xu (Author), Xue Yu (Author), Shuang Zhang (Author), Shuling Liu (Author), Yushan Gao (Author), Shuning Fan (Author), Changxiang Li (Author), Changming Zhai (Author), Fafeng Cheng (Author), Qingguo Wang (Author)
Format:	Book
Published:	BMC, 2019-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid
by: Chongyang Ma, et al.
Published: (2020)

Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury
by: Haiyan Li, et al.
Published: (2022)

TLR4 Enhances Cerebral Ischemia/Reperfusion Injury via Regulating NLRP3 Inflammasome and Autophagy
by: Li Mao, et al.
Published: (2023)

Chrysophanol Inhibits NALP3 Inflammasome Activation and Ameliorates Cerebral Ischemia/Reperfusion in Mice
by: Nan Zhang, et al.
Published: (2014)

Protective Effects of Remimazolam on Cerebral Ischemia/Reperfusion Injury in Rats by Inhibiting of NLRP3 Inflammasome-Dependent Pyroptosis
by: Shi M, et al.
Published: (2022)

Tilianin suppresses NLRP3 inflammasome activation in myocardial ischemia/reperfusion injury via inhibition of TLR4/NF-κB and NEK7/NLRP3
by: Suyue Yin, et al.
Published: (2024)

Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy
by: Jingxue Ye, et al.
Published: (2020)

Neuroprotective Effect of Taohong Siwu Decoction on Cerebral Ischemia/Reperfusion Injury via Mitophagy-NLRP3 Inflammasome Pathway
by: Zhao-Jie Ji, et al.
Published: (2022)

Corilagin alleviates intestinal ischemia/reperfusion-induced intestinal and lung injury in mice via inhibiting NLRP3 inflammasome activation and pyroptosis
by: Wenlian Li, et al.
Published: (2022)

Corrigendum: Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy
by: Jingxue Ye, et al.
Published: (2021)

NADPH Oxidase-Mediated Testicular Oxidative Imbalance Regulates the TXNIP/NLRP3 Inflammasome Axis Activation after Ischemia Reperfusion Injury
by: Duaah Almarzouq, et al.
Published: (2023)

Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study
by: Fafeng Cheng, et al.
Published: (2017)

Metformin ameliorates ferroptosis in cardiac ischemia and reperfusion by reducing NOX4 expression via promoting AMPKα
by: Zhenhua Wu, et al.
Published: (2023)

Dexmedetomidine Ameliorates Cardiac Ischemia/Reperfusion Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT3 Pathway
by: He H, et al.
Published: (2023)

Modified Citrus Pectin Alleviates Cerebral Ischemia/Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation via TLR4/NF-&kgreen;B Signaling Pathway in Microglia
by: Cui Y, et al.
Published: (2022)

QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
by: Meng Li, et al.
Published: (2022)

Role of caspase-11 non-canonical inflammasomes in retinal ischemia/reperfusion injury
by: Yong Wan, et al.
Published: (2024)

NLRP3 inflammasome in metabolic syndrome
by: Fang Wang, et al.
Published: (2021)

AMPK Activation Alleviates Myocardial Ischemia-Reperfusion Injury by Regulating Drp1-Mediated Mitochondrial Dynamics
by: Jingxia Du, et al.
Published: (2022)

Farrerol Alleviates Myocardial Ischemia/Reperfusion Injury by Targeting Macrophages and NLRP3
by: Lin Zhou, et al.
Published: (2022)

Baicalin Attenuates Oxygen-Glucose Deprivation/Reoxygenation-Induced Injury by Modulating the BDNF-TrkB/PI3K/Akt and MAPK/Erk1/2 Signaling Axes in Neuron-Astrocyte Cocultures
by: Changxiang Li, et al.
Published: (2021)

β-aminoisobutyrics acid, a metabolite of BCAA, activates the AMPK/Nrf-2 pathway to prevent ferroptosis and ameliorates lung ischemia-reperfusion injury
by: Ziyue Zhang, et al.
Published: (2023)

Corrigendum: AMPK activation alleviates myocardial ischemia-reperfusion injury by regulating Drp1-mediated mitochondrial dynamics
by: Jingxia Du, et al.
Published: (2024)

Activation of Nrf2 by Lithospermic Acid Ameliorates Myocardial Ischemia and Reperfusion Injury by Promoting Phosphorylation of AMP-Activated Protein Kinase α (AMPKα)
by: Min Zhang, et al.
Published: (2021)

Acute Lung Injury and the NLRP3 Inflammasome
by: Gu W, et al.
Published: (2024)

Irisin Attenuates Myocardial Ischemia/Reperfusion Injury and Improves Mitochondrial Function Through AMPK Pathway in Diabetic Mice
by: Chao Xin, et al.
Published: (2020)

Gastrodin Ameliorates Cognitive Dysfunction in Diabetes Rat Model via the Suppression of Endoplasmic Reticulum Stress and NLRP3 Inflammasome Activation
by: Tianyuan Ye, et al.
Published: (2018)

The role of NLRP3 inflammasome in hepatocellular carcinoma
by: Huijie Zhao, et al.
Published: (2023)

Neural Stem Cell-Conditioned Medium Ameliorated Cerebral Ischemia-Reperfusion Injury in Rats
by: HongNa Yang, et al.
Published: (2018)

Cyanidin-3-glucoside inhibits ferroptosis in renal tubular cells after ischemia/reperfusion injury via the AMPK pathway
by: Yi-Wei Du, et al.
Published: (2023)

Panax quinquefolius L. Saponins Protect Myocardial Ischemia Reperfusion No-Reflow Through Inhibiting the Activation of NLRP3 Inflammasome via TLR4/MyD88/NF-κB Signaling Pathway
by: Ping Yu, et al.
Published: (2021)

The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease
by: Ruixue Kong, et al.
Published: (2022)

Topiramate Reprofiling for the Attenuation of Cadmium-Induced Testicular Impairment in Rats: Role of NLRP3 Inflammasome and AMPK/mTOR-Linked Autophagy
by: Hany H. Arab, et al.
Published: (2022)

Neurodegenerative Disease and the NLRP3 Inflammasome
by: Jonathan A. Holbrook, et al.
Published: (2021)

Spotlight on the NLRP3 inflammasome pathway
by: Groslambert M, et al.
Published: (2018)

The role of the NLRP3 inflammasome in gout
by: Sarah R Kingsbury, et al.
Published: (2011)

<i>Epimedium</i> Aqueous Extract Ameliorates Cerebral Ischemia/Reperfusion Injury through Inhibiting ROS/NLRP3-Mediated Pyroptosis
by: Xiaoyu Wu, et al.
Published: (2023)

The Role of NLRP3 Inflammasome Signaling on Arrhythmias in Diabetes
by: Zhang L, et al.
Published: (2022)

AMPK/SIRT1 Pathway is Involved in Arctigenin-Mediated Protective Effects Against Myocardial Ischemia-Reperfusion Injury
by: Cheng-Yin Liu, et al.
Published: (2021)

EGCG protects the mouse brain against cerebral ischemia/reperfusion injury by suppressing autophagy via the AKT/AMPK/mTOR phosphorylation pathway
by: Li Wang, et al.
Published: (2022)